department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

ANASTROZOLE · pharmadog

pharmadog
drugs
ANASTROZOLE

drug

patient view →

ANASTROZOLE

Marketedupdated 2mo ago

by Stason Pharmaceuticals Inc

Approved

community read0 votes

indications

investigational

Breast Cancer

all catalysts(11)

approval · 11

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

ANASTROZOLE — FDA approval

view all 11 catalysts →

News(0)

no news has mentioned this drug yet

brand

ANASTROZOLE

generic

ANASTROZOLE

indication

Hormone Sensitive Breast Cancer

phase

marketed

Data sources

openFDA · ClinicalTrials.gov

last refreshed 53m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 7

tagApproval30 co-mentions · 15 sources
tagSmall Molecule15 co-mentions · 15 sources
tagRecall3 co-mentions · 3 sources
drugtestosterone3 co-mentions · 3 sources
drugTestim3 co-mentions · 3 sources
drugVogelxo3 co-mentions · 3 sources
drugBio T3 co-mentions · 3 sources

Trials studying ANASTROZOLE

phase2First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumorsrecruitingn=880
—Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russiarecruitingn=2,766
phase3Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)recruitingn=220
phase2Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Canceractive not recruitingn=40
phase3A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)recruitingn=920
phase3A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrencerecruitingn=4,220
phase3Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)active not recruitingn=315
phase1A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumorsactive not recruitingn=193

more trials →